Literature DB >> 35381273

Heterojunction engineered bioactive chlorella for cascade promoted cancer therapy.

Meitong Ou1, Chuchu Lin1, Ying Wang1, Yuting Lu1, Wenyan Wang1, Zimu Li1, Weiwei Zeng2, Xiaowei Zeng1, Xiaoyuan Ji3, Lin Mei4.   

Abstract

The hypoxic tumor microenvironment is one of most major hurdles restraining the anti-tumor efficiency of photodynamic therapy (PDT). Herein, active photosynthetic Chlorophyceae (Chlorella, Chl) functionalized with black phosphorus nanosheets (BPNSs) through polyaspartic acid (PASP) and Fe3+ mediating "Lego building method" are utilized for photocatalyzed oxygen-evolving to realize photosynthesis enhanced synergistic photodynamic/chemodynamic/immune therapy. The Chl cells with inherent photosynthesis and distinct metabolites are able to ameliorate tumor hypoxia, enhance immune cells infiltration, and stimulate the proliferation and maturation of immune cells. BPNSs loaded on the surface of Chl cells construct a type-II heterojunction with the chlorophyll in Chl cells, which improves the conversion efficiency of light through thoroughly separating photo-excited electrons and holes for 1O2 generation and O2 evolution, respectively. Additionally, the lock between "Lego bricks", Fe3+, can both consume glutathione (GSH) and catalyze Fenton reaction with H2O2 to generate ·OH, mediating chemodynamic therapy (CDT). Moreover, Chl@BP-Fe also exhibited high biocompatibility and potential biodegradability, guaranteeing high potential for clinic applications of this synergistic photodynamic/chemodynamic/immune therapy.
Copyright © 2022. Published by Elsevier B.V.

Entities:  

Keywords:  Chemodynamic therapy; Hypoxia alleviation; Immunotherapy; Photodynamic therapy; Photosynthesis

Mesh:

Substances:

Year:  2022        PMID: 35381273     DOI: 10.1016/j.jconrel.2022.03.059

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  4 in total

1.  Research progress of the engagement of inorganic nanomaterials in cancer immunotherapy.

Authors:  Tingwei Peng; Tianzhao Xu; Xinghui Liu
Journal:  Drug Deliv       Date:  2022-12       Impact factor: 6.819

Review 2.  Bifunctional scaffolds for tumor therapy and bone regeneration: Synergistic effect and interplay between therapeutic agents and scaffold materials.

Authors:  Jiongpeng Yuan; Zhaoyi Ye; Yaoxun Zeng; Zhenxing Pan; ZhenZhen Feng; Ying Bao; Yushan Li; Xujie Liu; Yan He; Qingling Feng
Journal:  Mater Today Bio       Date:  2022-06-09

Review 3.  Immune-regulating camouflaged nanoplatforms: A promising strategy to improve cancer nano-immunotherapy.

Authors:  Biao-Qi Chen; Yi Zhao; Yang Zhang; Yu-Jing Pan; Hong-Ying Xia; Ranjith Kumar Kankala; Shi-Bin Wang; Gang Liu; Ai-Zheng Chen
Journal:  Bioact Mater       Date:  2022-08-10

4.  Intelligent Drug Delivery by Peptide-Based Dual-Function Micelles.

Authors:  Dong Wan; Yujun Liu; Xinhao Guo; Jianxin Zhang; Jie Pan
Journal:  Int J Mol Sci       Date:  2022-08-26       Impact factor: 6.208

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.